Table 1 Patient and tumor characteristics
From: Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer
Characteristic | N (%) |
|---|---|
Age (median years, range) | 61 (33–87) |
Sex | |
Male | 35 (61.4) |
Female | 22 (38.6) |
Performance status (Eastern Cooperative Oncology Group) | |
1 | 26 (45.6) |
2 | 21 (36.8) |
3 | 8 (14.0) |
4 | 2 (3.5) |
Histopathology | |
Adenocarcinoma | 52 (91.2) |
Signet ring cell carcinoma | 5 (8.8) |
Stage (American Joint Committee on Cancer 8th revision) | |
IIA | 1 (1.8) |
IIB | 2 (3.5) |
IIIA | 2 (3.5) |
IIIB | 2 (3.5) |
IV | 50 (87.7) |
Chemotherapy | |
Before radiotherapy | 43 (75.4) |
During radiotherapy | 10 (17.5) |
After radiotherapy | 27 (47.4) |
Endoscopic hemostasis therapy before radiotherapy | |
No | 11 (19.3) |
Yes | 46 (80.7) |
Baseline hemoglobin (median g/dL, range) | 6.6 (3.9–9.9) |